Article
Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.
Cancer cytopathology - 1 Apr 2022
Tao Xiang, Austin R Marshall, Yu Ting, Zhong Fangfang, Zhou Xianrong, Cong Qing, Sui Long, Zhao Chengquan
Abstract excerpt
BACKGROUND: Extended high-risk human papillomavirus (hrHPV) genotype testing (hrHPVGT) has emerged as a new strategy to help optimize the efficiency of hrHPV triage. METHODS: Women with an atypical squamous cells of undetermined significance (ASC-US) cervical Papanicolaou test result who underwent hrHPVGT between October 2017 and May 2021 at the Obstetrics and Gynecology Hospital of Fudan University in Shanghai,...
Topics
- Atypical Squamous Cells of the Cervix
- China
- DNA, Viral
- Female
- Genotype
- Humans
- Papillomaviridae
- Papillomavirus Infections
- Pregnancy
- Retrospective Studies
- Risk Assessment
- Uterine Cervical Neoplasms